(Albany, US) DelveInsight's Geographic Atrophy Market Analysis Report proffers a comprehensive outlay of the Geographic Atrophy Epidemiological analysis focusing on the incidence and diagnosed patient pool segmented on the basis of several factors, as well as the Geographic Atrophy market analysis in the 7MM (the US, EU5 (the
The report covers the Geographic Atrophy market trends covering key pharmaceutical companies in the market, upcoming as well as Geographic Atrophy marketed therapies, unmet needs, prevailing constraints and the factors driving the market size growth.
Some of the significant Geographic Atrophy Report Highlights:
*Increase in GA market size anticipated for the study period 2018-2030 at a CAGR of 30.9%. *Globally, more than 5 million people are affected by GA. *In the year 2020, the total prevalent case of Geographic Atrophy was 2,969,911 cases in the 7MM. These cases are expected to grow with a significant CAGR in the study period 2018-2030. *In the 7MM, the total treated cases of Geographic Atrophy were 1,267,314 cases in 2020. *There are currently no approved Geographic Atrophy treatments. Several major players such as
Get more comprehensive insights into how Geographic Atrophy epidemiological trends are impacting current and forecasted Geographic Atrophy market @ Geographic Atrophy Epidemiology Analysis and Forecast
Some of Geographic Atrophy Companies:
*
Do you want to know how much market share the emerging therapies are going to capture by 2030? Contact @ Geographic Atrophy Marketed Therapies and Treatment Approaches and get a comprehensive understanding of the Geographic Atrophy therapeutic outlook.
The launch of the emerging therapies is expected to significantly impact the Geographic Atrophy treatment scenario in the upcoming years:-
Some of Geographic Atrophy Drugs Covered:
*Zimura (avacincaptad pegol) *Pegcetacoplan *HMR59/AAVCAGsCD59 *Risuteganib/ALG-1001/Luminate *Elamipretide *ALK-001 *GT005 *CPCB-RPE1 *RO7171009/RG6147 *IONIS-FB-LRx *OpRegen *Palucorcel/CNTO 2476 *And Many Others
Know more about the collaborations, tie-ups, and therapies launch @ Geographic Atrophy Pipeline Therapies and Forecast
Table of Contents:
1. Key Insights
2. Executive Summary of Geographic Atrophy
3. Competitive Intelligence Analysis for Geographic Atrophy
4. Geographic Atrophy: Market Overview at a Glance
5. Geographic Atrophy: Disease Background and Overview
6.
7. Geographic Atrophy Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Geographic Atrophy Treatment
11. Marketed Products
12. Emerging Therapies
13. Geographic Atrophy: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Geographic Atrophy
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
Request for Free Sample Report: https://www.delveinsight.com/sample-request/geographic-atrophy-ga-market
DelveInsght's
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Media Contact
Company
Contact Person:
Email: info@delveinsight.com
Phone: +19193216187
Address:
City: Albany
State:
Country:
Website: https://www.delveinsight.com/report-store/geographic-atrophy-ga-market
Source: www.abnewswire.com
.
(C) 2021 M2 COMMUNICATIONS, source